P614: NOVEL SPLICE-SITE MUTATION IN PLCG2 ASSOCIATED WITH RESISTANCE TO BTK INHIBITORS

• Jialei Qi,
• Martin Wist,
• Eugen Tausch,
• Deyan Yordanov Yosifov,
• Anja Schade,
• Xiang Gao,
• Rashmi Priyadharshini Dheenadayalan,
• Christof Schneider,
• Sascha Endres,
• Daniel Mertens,
• Peter Gierschik,
• Stephan Stilgenbauer,
• Billy Michael Chelliah Jebaraj

Affiliations

Jialei Qi

1 Ulm University, Department of Internal Medicine III, Division of CLL, Ulm, Germany

Martin Wist

2 Ulm University, Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm, Germany

Eugen Tausch

1 Ulm University, Department of Internal Medicine III, Division of CLL, Ulm, Germany

Deyan Yordanov Yosifov

1 Ulm University, Department of Internal Medicine III, Division of CLL, Ulm, Germany

Anja Schade

2 Ulm University, Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm, Germany

Xiang Gao

4 Ulm University, Department of Internal Medicine III, Ulm, Germany

Rashmi Priyadharshini Dheenadayalan

1 Ulm University, Department of Internal Medicine III, Division of CLL, Ulm, Germany

Christof Schneider

1 Ulm University, Department of Internal Medicine III, Division of CLL, Ulm, Germany

Sascha Endres

2 Ulm University, Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm, Germany

Daniel Mertens

1 Ulm University, Department of Internal Medicine III, Division of CLL, Ulm, Germany

Peter Gierschik

2 Ulm University, Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm, Germany

Stephan Stilgenbauer

1 Ulm University, Department of Internal Medicine III, Division of CLL, Ulm, Germany

Billy Michael Chelliah Jebaraj

1 Ulm University, Department of Internal Medicine III, Division of CLL, Ulm, Germany